Showing 12 of 52 recruiting trials for “primary-localized-amyloidosis”
Daratumumab for Patients With Light Chain Amyloidosis
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
👨⚕️ Janssen Research & Development, LLC Clinical Trial, Janssen Research & Development, LLC📍 29 sites📅 Started Nov 2022View details ↗
Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis
Venetoclax, MLN9708 (Ixazomib Citrate) and Dexamethasone for the Treatment of Relapsed or Refractory Light Chain Amyloidosis
👨⚕️ Michael A Rosenzweig, City of Hope Comprehensive Cancer Center LAO📍 16 sites📅 Started Aug 2022View details ↗
Isatuximab Plus Pomalidomide and Dexamethasone Association for Patients With AL Amyloidosis Not in VGPR or Better After Any Previous Therapy
RecruitingNCT05283993 ↗
A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH
RecruitingNCT04265040 ↗
DZHK TORCH-Plus is a Registry for Patients With Cardiomyopathies and Serves as Source for Cardiovascular Research Studies
Novel Imaging Tools in Newly-diagnosed Patients With Cardiac AL Amyloidosis
RecruitingNCT04839003 ↗
A Registry of AL Amyloidosis (ReAL)
RecruitingNCT03717844 ↗
Registry for Adults With Plasma Cell Disorders (PCD's)
👨⚕️ Sascha Tuchman, MD, UNC Lineberger Comprehensive Cancer Center📍 1 site📅 Started Feb 2018View details ↗
RecruitingNCT01408225 ↗
Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource
Enrolling by InvitationNCT04210791 ↗
Autologous Stem Cell Transplantation for Patients With AL Amyloidosis
← PreviousPage 3 of 3
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →